NASHVILLE, TN and HOUSTON, TX – March 10, 2022 – symplr®, the leader in enterprise healthcare operations, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) and Charlesbank Capital Partners (together with its affiliates, “Charlesbank”), today announced that it has entered into an agreement to purchase GreenLight Medical, Inc. (“GreenLight Medical”), a provider of healthcare supply chain management software.
“GreenLight Medical is a natural complement to our healthcare operations portfolio. The combination of symplr’s Spend Management offering and GreenLight’s software platform will enable financial leaders across health systems to make more informed spending decisions,” said BJ Schaknowski, CEO of symplr. “Healthcare systems today are seeking integrated and connected enterprise solutions. Our vision for symplr Spend Management is to deliver streamlined supply chain decision support, making it easier for leaders to make informed, timely, value-based, and defensible purchase decisions.”
GreenLight Medical’s cloud-based software platform is the first solution that provides healthcare organizations with quality and value-based data for evaluating, purchasing, and deploying new medical technology, streamlining collaborative and compliant purchasing decisions. Together, symplr and GreenLight Medical will offer one of the industry’s most comprehensive spend management and value analysis SaaS solutions, enhanced by symplr’s robust data warehouse with over 20 years of capital market intelligence and symplr’s Hayes clinical evidence software solution. By connecting these solutions into one comprehensive view, the consolidated symplr platform will dramatically improve spend management, as well as critical financial and clinical outcomes.